Europe

New US plan could allow fivefold increase in monkeypox vaccination

President Joe Biden’s administration announced Tuesday that the Food and Drug Administration (FDA) has authorized a change in vaccine administration protocol which could increase by 500 percent the number of people in the United States who receive the monkeypox vaccine.

“A game changer,” was how the White House monkeypox response coordinator, Robert Fenton, characterized the decision.

Under the emergency use authorization issued by the FDA, medical providers will be allowed to administer one-fifth of a full dose of the Jynneos vaccine to adults using a technique known as intradermal vaccination: depositing the vaccine into rather than under the skin.

File source

Tags
Show More

Related Articles

Back to top button
Close